Avidity Biosciences
RNA
$19.07
Share price
-1.29%
Change (1 day)
-1.19%
Change (1 year)
Categories
Earnings for Avidity Biosciences (RNA)
Earnings in 2022 (TTM): -$0.13 B
According to Avidity Biosciences's latest financial reports the company's current earnings (TTM) are -$0.13 B. In 2021 the company made an earning of -$0.12 B a decrease over its 2020 earnings that were of -$0.05 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Avidity Biosciences from 2019 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -$0.13 B | 8.81% |
| 2021 | -$0.12 B | 166.06% |
| 2020 | -$0.05 B | 79.33% |
| 2019 | -$0.03 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $33.77 B | -26,402.18% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.80 B | -6,175.09% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | -$0.51 B | 290.99% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.52 B | 298.79% | 🇺🇸 USA |
 Fate Therapeutics
FATE | -$0.28 B | 115.53% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.07 B | -47.85% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -$0.26 B | 98.98% | 🇺🇸 USA |